This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.
Information
- Show
- PublishedJuly 30, 2020 at 4:47 PM UTC
- Length25 min
- Season1
- RatingClean
